- Home
- AVIR vs GLAD Comparison
AVIR vs GLAD Comparison
Compare AVIR & GLAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVIR | GLAD |
|---|---|---|
| Founded | 2012 | 2001 |
| Country | United States | United States |
| Employees | N/A | 65 |
| Industry | Medicinal Chemicals and Botanical Products | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 434.5M | 427.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVIR | GLAD |
|---|---|---|
| Price | $4.57 | $18.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $10.00 | ★ $22.33 |
| AVG Volume (30 Days) | ★ 259.4K | 160.8K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 9.78% |
| EPS Growth | ★ 3.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | $15.16 |
| Revenue Next Year | N/A | $5.10 |
| P/E Ratio | ★ N/A | $11.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.78 | $16.54 |
| 52 Week High | $6.45 | $29.50 |
Technical Indicators
Market Signals| Indicator | AVIR | GLAD |
|---|---|---|
| Relative Strength Index (RSI) | 51.59 | 43.78 |
| Support Level | $4.14 | $18.06 |
| Resistance Level | $4.59 | $18.94 |
| Average True Range (ATR) | 0.18 | 0.45 |
| MACD | 0.06 | -0.09 |
| Stochastic Oscillator | 94.44 | 27.74 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
About GLAD Gladstone Capital Corporation
Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.